New Jersey Senate Bill S1327

New Jersey 2022-2023 Regular Session

• Introduced: 2/3/22
• Refer: 2/3/22

Caption

Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

Impact

The implications of S1327 on state laws include amendments to the existing prescription monitoring program established under P.L.2007, c.244. By establishing a mechanism for patients to express their wishes regarding opioid prescriptions, the bill seeks to improve the management of prescriptions and address the growing concern of substance abuse. This could lead to better-informed prescribing practices among healthcare providers and potentially reduce the risk of addiction or misuse of controlled substances.

Summary

Senate Bill S1327 aims to enhance patient autonomy by allowing individuals to indicate their preference not to be prescribed opioid drugs or other controlled substances that have a high potential for abuse. The bill requires the Division of Consumer Affairs within the Department of Law and Public Safety to create a formal process enabling patients to request that their prescription monitoring information reflect this preference. Notably, this indication would be made at the patient's discretion, emphasizing the importance of patient consent and autonomy in treatment decisions. Additionally, the bill outlines procedures for patients to remove such indications if they choose to do so later.

Contention

While S1327 is primarily framed as a means to aid recovery and ensure better patient outcomes, some potential points of contention could arise regarding the responsibilities of healthcare providers. Questions may emerge about how practitioners will verify and honor a patient's request, especially in emergency situations where a patient's ability to communicate may be compromised. Additionally, concerns may be raised about the implications for patients who may genuinely require pain management but have previously indicated a preference against certain medications.